BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3111953)

  • 41. [Substitution therapy using antithrombin III concentrate].
    Thaler E; Lechner K
    Dtsch Med Wochenschr; 1982 Jan; 107(4):147-9. PubMed ID: 7056170
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 43. The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients.
    Koami H; Sakamoto Y; Sakurai R; Ohta M; Imahase H; Yahata M; Umeka M; Miike T; Nagashima F; Iwamura T; Yamada KC; Inoue S
    Thromb Res; 2017 Sep; 157():84-89. PubMed ID: 28711778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-coagulant therapy--antithrombin III].
    Tsuji H
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
    Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti DIC therapy].
    Yahata M; Sakamoto Y
    Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic use of antithrombin concentrate in sepsis.
    Balk R; Emerson T; Fourrier F; Kruse JA; Mammen EF; Schuster HP; Vinazzer H
    Semin Thromb Hemost; 1998; 24(2):183-94. PubMed ID: 9579641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnosis and management of acute obstetrical DIC.
    Kobayashi T; Terao T; Maki M; Ikenoue T
    Semin Thromb Hemost; 2001; 27(2):161-7. PubMed ID: 11372771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver disease in pregnancy with DIC and low levels of AT III.
    Jespersen J
    Scand J Haematol; 1983 May; 30(5):493-4. PubMed ID: 6857155
    [No Abstract]   [Full Text] [Related]  

  • 51. Substitution of antithrombin III in shock and DIC: a randomized study.
    Blauhut B; Kramar H; Vinazzer H; Bergmann H
    Thromb Res; 1985 Jul; 39(1):81-9. PubMed ID: 4035650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child.
    Favier R; Deschamps A; Belhocine R; Ankri A; Costil J; de Moerloose P
    Hematol Cell Ther; 1998 Apr; 40(2):67-70. PubMed ID: 9615249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum.
    Martí-Carvajal AJ; Comunián-Carrasco G; Peña-Martí GE
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD008577. PubMed ID: 21412921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of disseminated intravascular coagulation].
    Asakura H
    Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of DIC with antithrombin III concentrates.
    Sakata Y; Yoshida N; Matsuda M; Aoki N
    Bibl Haematol; 1983; (49):307-16. PubMed ID: 6667252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.